WO2010015211A1 - Synthesis of oxazoline compounds - Google Patents

Synthesis of oxazoline compounds Download PDF

Info

Publication number
WO2010015211A1
WO2010015211A1 PCT/CN2009/073136 CN2009073136W WO2010015211A1 WO 2010015211 A1 WO2010015211 A1 WO 2010015211A1 CN 2009073136 W CN2009073136 W CN 2009073136W WO 2010015211 A1 WO2010015211 A1 WO 2010015211A1
Authority
WO
WIPO (PCT)
Prior art keywords
optionally substituted
process according
compound
fluoride
organic basic
Prior art date
Application number
PCT/CN2009/073136
Other languages
French (fr)
Inventor
Albert Sun-Chi Chan
Kai Ding
Wing-Yiu Yu
Original Assignee
The Hong Kong Polytechnic University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Hong Kong Polytechnic University filed Critical The Hong Kong Polytechnic University
Publication of WO2010015211A1 publication Critical patent/WO2010015211A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/22Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/12Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals containing only hydrogen and carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57Aryl or substituted aryl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Definitions

  • the invention is directed to a novel process for preparing oxazoline compounds.
  • Oxazoline compounds are five-membered nitrogen heterocycles that are of great interest to organic chemistry.
  • optically active oxazolines have been proven to be useful as effective auxiliaries and ligands for selected asymmetric syntheses.
  • Oxazolines have been used as monomers in ring opening polymerizations and have been used as protecting groups for carboxyl moieties in organic synthesis.
  • Oxazolines are valuable intermediates in organic synthesis.
  • Several methods have been developed for the synthesis of oxazoline compounds. The most common synthesis method is by dehydrative cyclization of N- acylamino alcohols.
  • Acid-insensitive substrates such as molybdenum oxide, BF 3 - Et 2 O and TsOH as Lewis or Br ⁇ nsted acid catalysts have been used for this cyclization reaction, as reported by A. Sakakura et al., Org. Lett, 7, 1971 -1974 (2005) and P. Chaudhry et al., J. Comb. Chem., 9, 473-476 (2007).
  • electrophilic reagents such as SOCI 2 , TsCI, PPh 3 /CCI 4 , Vilsmeier Reagent, DAST, or Deoxo-Fluorand Burgess reagent have been used to activate the hydroxyl group of the amino alcohols, as reported by P.
  • the present invention provides an improved process for preparing an oxazoline compound of the formula:
  • Ri and R 2 are independently hydrogen, sulfide, sulfoxide, sulfonyl, optionally substituted lower alkyl, optionally substituted aralkyl, optionally substituted aryl or optionally substituted polycyclic arylyl; or
  • Ri and R 2 combined together with the carbon atoms to which they are attached form an optionally substituted fused 6-member aromatic ring provided that Ri and R 2 are attached to carbon atoms adjacent to each other;
  • R 3 is hydrogen, sulfide, sulfoxide, sulfonyl, optionally substituted lower alkyl, optionally substituted aralkyl, optionally substituted aryl or optionally substituted polycyclic arylyl.
  • the invention provides an improved process for preparing an oxazoline compound from its corresponding acylamino alcohol compound using a fluoroalkanesulfonyl fluoride compound to effect cyclization.
  • the process comprises the step of contacting an acylamino alcohol compound to an oxazoline compound in the presence of a suitable organic basic reagent and a compound of the formula:
  • Ri is a fluorinated alkyl or aryl; or an isomer therof; or an isomeric mixture thereof.
  • the process of the present invention provides a simple process to prepare oxazoline compounds in excellent yields and selectivities.
  • a fluoroalkanesulfonyl fluoride compound as a reagent, the present invention has the advantages of providing a process to efficiently convert acylamino alcohol compounds into oxazoline compounds with a remarkable variety of substrates, high chemoselectivity, mild conditions and relatively short reaction time.
  • the present invention has the further advantage of providing a process for preparing oxazoline compounds whose stereoisomeric configuration can be easily determined aforehand simply by the selection of the appropriate starting materials.
  • optionally substituted alkyl refers to unsubstituted or substituted straight or branched-chain hydrocarbon groups having 1 -20 carbon atoms, preferably 1 -7 carbon atoms.
  • exemplary unsubstituted alkyl groups include methyl, ethyl, propyl, isopropyl, n-butyl, f-butyl, isobutyl, pentyl, neopenthyl, hexyl, isohexyl, heptyl, octyl and the like.
  • Substituted alkyl groups include, but are not limited to, alkyl groups substituted by one or more of the following groups: halo, cyano, hydroxyl, acyl, alkoxy, carboxyl, amino, alkylamino, dialkylamino, cycloalkyl, alkenyl, or heterocyclyl.
  • lower alkyl refers to those optionally substituted alkyl groups as described above having 1-7 carbon atoms.
  • alkoxy refers to optionally substituted alkyl-O-.
  • alkenyl refers to any of the above alkyl groups having at least two carbon atoms and further containing a carbon to carbon double bond at the point of attachment.
  • alkynyl refers to any of the above alkyl groups having at least two carbon atoms and further containing a carbon to carbon triple bond at the point of attachment.
  • halogen refers to fluorine, chlorine, bromine and iodine.
  • cycloalkyl refers to optionally substituted monocyclic aliphatic hydrocarbon groups of 3-6 carbon atoms, which may be substituted by one or more substitutents, such as optionally substituted alkyl, aryl, halo, cyano, hydroxyl, carboxyl, and amino.
  • exemplary monocyclic hydrocarbon groups include, but are not limited to, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl and the like.
  • alkylamino and “dialkylamino” refer to alkyl-NH- and (alkyl) 2 N-, respectively.
  • aryl refers to a carbocyclic moiety containing at least one benzenoid-type ring, with the aryl groups preferably containing from 6 to 15 carbon atoms, for example, phenyl, naphthyl, indenyl or indanyl, which may optionally be substituted by 1 -4 substitutents, such as optionally substituted alkyl, aryl, cyano, carboxyl, amino, halo or alkoxy.
  • polycyclic arylyl refers to an optionally substituted, fully saturated or unsaturated, aromatic or non-aromatic cyclic group, for example, which is a 4- to 7-membered monocyclic, 7- to 12- membered bicyclic, or 10- to 15-membered tricyclic ring system.
  • Substituted polycyclic aryl groups refer to polycyclic groups substituted with 1 , 2 or 3 substituents selected from the group consisting of: optionally substituted alkyl, halo, cyano, hydroxyl, carboxyl, and amino.
  • aralkyl refers to an aryl group bonded directly through an alkyl group, such as benzyl or phenethyl.
  • heterocyclyl refers to an optionally substituted, fully saturated or unsaturated, aromatic or non-aromatic cyclic group, for example, which is a 4- to 7-membered monocyclic, 7- to 12- membered bicyclic, or 10- to 15- membered tricyclic ring system, which has at least one heteroatom in at least one carbon atom containing ring.
  • Each ring of the heterocyclic group containing a heteroatom may have 1 , 2 or 3 heteroatoms selected from nitrogen atoms, oxygen atoms and sulfur atoms, where the nitrogen and sulfur heteroatoms may also optionally be oxidized.
  • the heterocyclic group may be attached at a heteroatom or a carbon atom.
  • heterocyclyl includes substituted heterocyclic groups.
  • Substituted heterocyclic groups refer to heterocyclic groups substituted with 1 , 2 or 3 substituents selected from the group consisting of: optionally substituted alkyl, halo, cyano, hydroxyl, and amino.
  • fluorinated alkyl refers to a fluorinated alkyl group having from 1 to about 10 carbon atoms; substituted or fluorinated ether groups (e.g., HC 2 F 4 OC 2 F 4 -, IC 2 F 4 OC 2 F 4 -, CIC 2 F 4 OC 2 F 4 -); or substituted or fluorinated esther groups (e.g., MeOOCCF 2 -).
  • fluorinated aryl refers to a fluorinated cycloalkyl group having from about 4 to 8 carbon atoms.
  • the present invention relates to a method for preparing oxazoline compounds of formula (I) with a suitable organic basic reagent and a fluoroalkanesulfonyl fluoride compound of formula (II).
  • the process of the present invention is particularly useful to prepare high yields of a chemospecific oxazoline compound.
  • the process of the present invention is particularly useful to prepare an oxazoline compound with a remarkable variety of substrates, mild conditions and relatively short reaction time.
  • acylamino alcohols suitable for use with the process of the invention include compounds of the formula: wherein
  • Ri and R 2 are independently hydrogen, sulfide, sulfoxide, sulfonyl, optionally substituted lower alkyl or alkenyl or alkynyl, optionally substituted aralkyl, optionally substituted aryl or optionally substituted polycyclic arylyl; or
  • Ri and R 2 combined together with the carbon atoms to which they are attached form an optionally substituted fused 6-member aromatic ring provided that Ri and R 2 are attached to carbon atoms adjacent to each other;
  • R 3 is hydrogen, sulfide, sulfoxide, sulfonyl, optionally substituted lower alkyl, optionally substituted aralkyl, optionally substituted aryl or optionally substituted polycyclic arylyl.
  • the acylamino alcohols useful in the present invention include N-acylamino alcohols, wherein R 2 in the compound of formula (III) is hydrogen, or an N-acyl-1 ,2- disubstituted amino alcohol
  • the acylamino alcohols useful in the present invention are known compounds that are industrially produced and available commercially. Representative methods of preparing N-acylamino alcohols are described in European Patent Application 0075868. However, other methods of preparing N-acylamino alcohols that are well- known to one skilled in the art may be used. The preparative teachings of these references are incorporated herein by reference.
  • Sulfonyl fluoride compounds suitable for use in the process of the invention are fluorinated saturated aliphatic or alicyclic sulfonyl fluorides.
  • a useful class of such fluoroalkanesulfonyl fluoride compounds can be represented by the general formula R 1 SO 2 F, where Ri is selected from the group consisting of fluorinated alkyl groups having from 1 to about 10 carbon atoms and fluorinated cycloalkyl groups having from about 4 to about 8 carbon atoms.
  • Ri is a perfluorinated alkyl group.
  • Representative samples of fluoroalkanesulfonyl fluoride compounds suitable for the use in the process of this invention include CF 3 SO 2 F, C 2 F 5 SO 2 F, C 4 F 9 S ⁇ 2 F, C 6 Fi 3 SO 2 F, C 8 Fi 7 SO2F, Ci 0 F 2 iSO 2 F, cyclo-(C 6 Fn)SO 2 F, C 2 F 5 -cyclo-(C 6 Fi 0 )SO 2 F, H(CF 2 ) 4 SO 2 F, H(CF 2 ) 8 SO 2 F, and mixtures thereof.
  • perfluorobutanesulfonyl fluoride perfluorohexanesulfonyl fluoride, perfluoroctane sulfonyl fluoride, and mixtures thereof are utilized.
  • perfluorobutanesulfonyl fluoride is utilized in the process of the present invention.
  • the fluoroalkanesulfonyl fluoride compounds of the present invention are industrially produced and available commercially as fine chemicals. Representative methods of preparing the fluoroalkanesulfonyl fluoride compounds of formula (II) are described in U.S. Patent Nos. 2,732,398; 5,318,674 and 5,486,281.
  • the fluoroalkanesulfonyl fluoride fluoride compound may be used in molar ratios (moles sulfonyl fluoride compound to moles amino alcohol) ranging from about 100 to 0.1 :1 , more preferably from about 10 to 0.1 :1 , most preferably about 1.5 : 1.
  • This claimed method for converting acylamino alcohols to oxazoline compounds by fluoroalkanesulfonyl fluoride compounds may be performed with untreated organic basic reagents commonly containing 0.1 - 4 percent of water, more preferably about 0.05 - 0.5 percent of water.
  • Organic basic reagents suitable for use in the process of the invention include a non-aqueous base such as lithium diisopropyl amide, lithium hexamethylsilazide, sodium hexamethylsilazide and potassium hexamethylsilazide; or potassium t-butoxide and sodium methoxide.
  • the base can be an alkali metal carbonate such as sodium, potassium, lithium or cesium carbonate or an alkaline earth metal carbonate such as calcium or barium carbonate; hydroxides such as sodium and potassium hydroxides; and hydrides such as sodium or potassium hydrides.
  • alkali metal carbonate such as sodium, potassium, lithium or cesium carbonate
  • alkaline earth metal carbonate such as calcium or barium carbonate
  • hydroxides such as sodium and potassium hydroxides
  • hydrides such as sodium or potassium hydrides.
  • the base can also be ammonia (NH 3 ) or an organic base including urea; a secondary amine such as dimethylamine, diphenylamine, N-methyl N-propylamine, diethylamine, diisopropylamine, N-methylaniline, piperazine, piperidine, pyrrolidine; or a tertiary amine such as diisopropylethylamine (DIPEA), trimethylamine, dimethylaniline, N,N-dimethylpropylamine, N,N-dimethylpiperidine, N,N-dimethylbutylamine, triethylamine (TEA).
  • DIPEA diisopropylethylamine
  • TAA triethylamine
  • the base can also be an heterocyclic nitrogen containing compound such as isoquinoline, morpholine, purine, pyridine, pyrazine, pyrimidine, quinoline or polyvinyl pyridine, preferably DMAP or DBU. Where appropriate, mixtures of any of the above bases can be employed.
  • an heterocyclic nitrogen containing compound such as isoquinoline, morpholine, purine, pyridine, pyrazine, pyrimidine, quinoline or polyvinyl pyridine, preferably DMAP or DBU.
  • the organic basic reagent may be used in molar ratios (moles base to moles amino alcohol) ranging from about 1 ,000 to 0.001 : 1 , more preferably from about 10 to 0.01 : 1 , most preferably about 3: 1.
  • the claimed method of the present invention may be performed by additionally including an inert organic solvent such as toluene, hexane, pentane, benzene, acetonitrile, acetone, tetrahydrofuran (THF), ethyl acetate, dichloromethane (CH 2 Cb or DCM), triethylamine, CDCI 3 Or a mixture of solvents thereof.
  • an inert organic solvent such as toluene, hexane, pentane, benzene, acetonitrile, acetone, tetrahydrofuran (THF), ethyl acetate, dichloromethane (CH 2 Cb or DCM), trie
  • the method of the present invention includes dichloromethane or CDCI 3 .
  • the N- acylamino alcohol of formula (III) is contacted with a fluoroalkanesulfonyl fluoride compound of formula (II) and an organic basic reagent in amounts and under conditions effective to yield the desired oxazoline compound.
  • the contacting may optionally be performed in an inert organic solvent.
  • the fluoroalkanesulfonyl fluoride compound (II) and organic basic reagent are contacted with the N-acylamino alcohol at temperatures ranging from 19-25°C, preferably from about 21 -23°C, most preferably at 22°C.
  • the contact is performed at ambient pressures although pressures greater or less than ambient can be employed.
  • the contacting of the reactants can be carried out for about 3 minutes to about 48 hours until the reaction is substantially completed, preferably from about 5 minutes about 24 hours.
  • the mixture is preferably stirred while the reactants are being contacted.
  • oxazoline can be removed from remaining water by extraction from methylene chloride or other methods well known to one skilled in the art.
  • the oxazoline is preferably formed in yield of at least about 55 percent based upon the initial amount of the N-acylamino alcohol, more preferably in yields of at least 85 percent, and most preferably in yields of at least about 87 percent.
  • Ri is sulfide, sulfoxide, sulfonyl, optionally substituted lower alkyl, optionally substituted aralkyl, optionally substituted aryl or optionally substituted polycyclic arylyl;
  • R 2 is sulfide, sulfoxide, sulfonyl, optionally substituted lower alkyl, optionally substituted aralkyl, optionally substituted aryl or optionally substituted polycyclic arylyl.
  • Table 1 illustrates that the method of the present invention may be used with a wide range of acylamino alcohol substrates to form their corresponding oxazoline compound. All the substituted derivatives 1 a - 1 q (entries 1-17), including those amides containing heterocyclic substituents 11 and 1 m, were readily converted to their corresponding oxazolines in nearly quantitative yields.
  • the present invention is an effective method for the preparation of an oxazoline compound with high chemoselectivity.
  • Cyclization of N-acylamino alcohols bearing an unprotected second hydroxyl group can be achieved with careful addition of perfluorobutanesulfonyl fluoride with DBU as a base.
  • DBU perfluorobutanesulfonyl fluoride
  • N- acylamino alcohol 1 q bearing an unprotected secondary hydroxyl group was cyclized to form oxazoline compound 2q (93% isolated yield) with careful addition of 1.1 -1.2 equiv of PFBSF with DBU as base in 5 ml_ of dichloromethane as solvent.
  • the present invention provides a method for the preparation of serine-derived oxazolines, which are interesting moieties of some natural products.
  • N-acylamino alcohols may be reacted with a fluorinated, sulfonyl fluoride and organic basic reagent to form oxazolines derived from serine.
  • this embodiment of the present invention preferably uses perfluorobutanesulfonyl fluoride as the fluoroalkanesulfonyl fluoride compound.
  • This embodiment of the present invention also uses DIPEA or DMAP as an organic basic reagent.
  • Oxazoline compounds 2r - 2w were synthesized using perfluorobutanesulfonyl fluoride and DMAP at approximately 90 percent yield. Further, oxazoline compounds 2x and 2y were synthesized using perfluorobutanesulfonyl fluoride and DIPEA at 85-87 percent yield .
  • the method of the present invention may be used to prepare 2,4,5-trisubstituted oxazoline compounds of formula (I), wherein Ri and R 2 are independently hydrogen, sulfide, sulfoxide, sulfonyl, optionally substituted lower alkyl, optionally substituted aralkyl, optionally substituted aryl or optionally substituted polycyclic arylyl; or Ri and R 2 combined together with the carbon atoms to which they are attached form an optionally substituted fused 6-member aromatic ring provided that Ri and R 2 are attached to carbon atoms adjacent to each other; and R 3 is sulfide, sulfoxide, sulfonyl, optionally substituted lower alkyl, optionally substituted aralkyl, optionally substituted aryl or optionally substituted polycyclic arylyl.
  • Ri and R 2 are independently hydrogen, sulfide, sulfoxide, sulfonyl, optionally substituted lower alkyl, optionally substitute
  • an N-acyl-1 ,2-disubstituted amino alcohol is contacted with a fluoroalkanesulfonyl fluoride compound of formula (II) and an organic basic reagent in amounts and under conditions effective to yield the desired oxazoline compound.
  • the fluoroalkanesulfonyl fluoride compound (II) and organic basic reagent are contacted with the N-acylamino alcohol at temperatures ranging from 19-25°C, preferably from about 21-23°C, most preferably at 22°C.
  • the contact is performed at ambient pressures although pressures greater or less than ambient can be employed.
  • the contacting of the reactants can be carried out for about 3 minutes to about 48 hours until the reaction is substantially completed, preferably from about 5 minutes about 24 hours.
  • the mixture is preferably stirred while the reactants are being contacted.
  • Table 2 illustrates that the method of the present invention may be used to prepare 2,4,5-trisubstituted oxazoline compound with regiochemical specificity. It is known that the analogous reaction using conventional activating reagents (e.g. TsCI) often requires more forceful conditions because of increased steric hindrance for the cyclization with secondary alcohols. Moreover, it is further known that 1 ,2- disubstituted amino alcohols are rather prone to epimerization via the S N 1 pathway. In one embodiment, the method of the present invention may be used to convert 1 , 2-disubstituted amino alcohols to an oxazoline compound with an inverted configuration. As set forth in Table 2, the acylamino alcohol 3a may be contacted with perfluorobutanesulfonyl fluoride and DBU to synthesize the oxazoline compound 4a at 98% yield.
  • TsCI activating reagents
  • the method of the present invention may be used to produce numerous 2, 4, 5- trisubstituted oxazoline compounds at high yield.
  • a 1 , 2-disubstituted amino alcohol By reacting a 1 , 2-disubstituted amino alcohol with a suitable amount of fluoroalkanesulfonyl fluoride compound and organic basic reagent, the method of the present invention may be efficiently employed with a variety of substrates, including for example, substrates derived from erythro-am ⁇ no alcohols, ⁇ /-acylamino indanol, and other common 1 , 2-disubstituted amino alcohols that are known to one skilled in the art.
  • the method of the present invention may be used to synthesize higher yields of 4, 5-oxazoline from ffrreo-amides than available with conventional techniques using, for example, reagents such as BF 3 - Et 2 O or TsCI.
  • reagents such as BF 3 - Et 2 O or TsCI.
  • Formation of 4, 5-oxazoline from threo-am ⁇ de is known to be problematic due to unfavored non-bonding interaction resulting in the formation of the thermally stable 4,5-frans-isomer rather than c/s-oxazoline.
  • the method of the present invention may be used to effect cyclization of threo-am ⁇ de compound 3h with a suitable amount of perfluorobutanesulfonyl fluoride and DBU as base to form c/s-4h in 55% isolated yield along with ⁇ 10% frans-isomer (entry 8).
  • Oxazolines synthesized by the present process are useful monomers for making known functional polymers that are used as effective auxiliaries and ligands for selected asymmetric syntheses, monomers in ring opening polymerizations, and valuable intermediates in organic synthesis.
  • the present invention providing a process to efficiently prepare a high yield of highly chemoselective oxazoline compounds from acylamino alcohol compounds under mild conditions and relatively short reaction time.
  • the simple protocol for the present invention provides an excellent opportunity for large-scale applications.
  • the following Examples are intended to further illustrate the invention and are not to be construed as being limitations otherwise.
  • N-acylamino alcohol 0.5 mmol
  • DBU 3.0 mmol
  • 5 ml_ of CH 2 CI 2 at 0 0 C are charged into a 25 ml_ flask with a magnetic stirring bar.
  • Perfluorobutanesulfonylfluoride 1.5 mmol
  • the mixture is stirred for 5 minutes at room temperature and then concentrated under reduced pressure.
  • the residue is purified by flash column chromatography on silica gel (1 :10 ethyl acetate: hexane) giving 2,4-diphenyl-4,5-dihydrooxazole in 99 percent yield.
  • N-acylamino alcohol (compound I q)(0.5 mmol), perfluorobutanesulfonyl fluoride (0.75 mmol), and DIPEA (1.5 mmol) are charged into a 25 ml_ flask with a magnetic stirring bar. 5 ml_ of CH 2 Cb is added to the 25 ml_ flask. The mixture is stirred for 24 hours at room temperature.
  • N-acylamino alcohol (compound 1 r)(0.5 mmol), perfluorobutanesulfonyl fluoride (0.75 mmol), and DIPEA (1.5 mmol) are charged into a 25 ml_ flask with a magnetic stirring bar. 5 ml_ of CH 2 CI 2 is added to the 25ml_ flask. The mixture is stirred for 24 hours at room temperature.
  • N-acylamino alcohol (compound 1x)(0.5 mmol), perfluorobutanesulfonyl fluoride (0.75 mmol), and DIPEA (1.5 mmol) are charged into a 25 ml_ flask with a magnetic stirring bar. 5 ml_ of CH 2 Cb is added to the 25ml_ flask. The mixture is stirred for 24 hours at room temperature.
  • Amide 3b (5.0 mmol), perfluorobutanesulfonyl fluoride (7.50 mmol), and DBU (15.0 mmol) are charged into a 50 ml_ flask with a magnetic stirring bar. 10 ml_ of CH 2 Cb is added to the 5OmL flask. The mixture is stirred for 30 minutes at room temperature. The residue is purified by flash column chromatography on silica gel (1 :10 ethyl acetate: hexane) giving 4-methyl-2,5-diphenyl-4,5-dihydrooxazole in 99 percent yield.

Abstract

The present invention provides an improved process for preparing an oxazoline compound of the formula: (I) wherein R1 and R2 are independently hydrogen, sulfide, sulfoxide, sulfonyl, optionally substituted lower alkyl, optionally substituted aralkyl, optionally substituted aryl or optionally substituted polycyclic arylyl; or R1 and R2 combined together with the carbon atoms to which they are attached form an optionally substituted fused 6-member aromatic ring provided that R1 and R2 are attached to carbon atoms adjacent to each other; and R3 is hydrogen, sulfide, sulfoxide, sulfonyl, optionally substituted lower alkyl, optionally substituted aralkyl, optionally substituted aryl or optionally substituted polycyclic arylyl; or an enantiomer therof; or an enantiomeric mixture therof; comprising the step of contacting an acylamino alcohol compound to a suitable amount of fluoroalkanesulfonyl fluoride compound and organic basic reagent. By using a fluoroalkanesulfonyl fluoride compound with an organic basic reagent, the present invention efficiently converts acylamino alcohol compounds into highly chemoselective oxazoline compounds with a remarkable variety of substrates, mild conditions and relatively short reaction time.

Description

SYNTHESIS OF OXAZOLINE COMPOUNDS
Field of the Invention
The invention is directed to a novel process for preparing oxazoline compounds.
Background of the Invention
Oxazoline compounds are five-membered nitrogen heterocycles that are of great interest to organic chemistry. Present in some biologically active natural products, optically active oxazolines have been proven to be useful as effective auxiliaries and ligands for selected asymmetric syntheses. Oxazolines have been used as monomers in ring opening polymerizations and have been used as protecting groups for carboxyl moieties in organic synthesis. Oxazolines are valuable intermediates in organic synthesis. Several methods have been developed for the synthesis of oxazoline compounds. The most common synthesis method is by dehydrative cyclization of N- acylamino alcohols. Acid-insensitive substrates such as molybdenum oxide, BF3- Et2O and TsOH as Lewis or Brønsted acid catalysts have been used for this cyclization reaction, as reported by A. Sakakura et al., Org. Lett, 7, 1971 -1974 (2005) and P. Chaudhry et al., J. Comb. Chem., 9, 473-476 (2007). Alternatively, electrophilic reagents such as SOCI2, TsCI, PPh3/CCI4, Vilsmeier Reagent, DAST, or Deoxo-Fluorand Burgess reagent have been used to activate the hydroxyl group of the amino alcohols, as reported by P. Wuts et al., J. Org. Chem., 65, 9223-9225 (2000) and P. Lafargue et al., Heterocycles, 41 , 947-958 (1995). However, these synthesis methods are disadvantageous since they are not applicable to various structural types and often require long reaction time under harsh reaction conditions. Thus, the development of a process to prepare oxazoline compounds at a rapid rate and high yield is an important challenge. It is desireable to provide a process for preparing oxazolines that is simple to operate and produces highly chemoselective compounds at high yield. It is also desireable to provide a process for preparing oxazolines which requires a short reaction time and mild conditions. This desired process is generally applicable to a wide variety of substrates.
Summary of the Invention
The present invention provides an improved process for preparing an oxazoline compound of the formula:
Figure imgf000003_0001
wherein
Ri and R2 are independently hydrogen, sulfide, sulfoxide, sulfonyl, optionally substituted lower alkyl, optionally substituted aralkyl, optionally substituted aryl or optionally substituted polycyclic arylyl; or
Ri and R2 combined together with the carbon atoms to which they are attached form an optionally substituted fused 6-member aromatic ring provided that Ri and R2 are attached to carbon atoms adjacent to each other; and
R3 is hydrogen, sulfide, sulfoxide, sulfonyl, optionally substituted lower alkyl, optionally substituted aralkyl, optionally substituted aryl or optionally substituted polycyclic arylyl.
The invention provides an improved process for preparing an oxazoline compound from its corresponding acylamino alcohol compound using a fluoroalkanesulfonyl fluoride compound to effect cyclization. The process comprises the step of contacting an acylamino alcohol compound to an oxazoline compound in the presence of a suitable organic basic reagent and a compound of the formula:
o
Il
R1 — S — F
Il
° do
wherein Ri is a fluorinated alkyl or aryl; or an isomer therof; or an isomeric mixture thereof.
The process of the present invention provides a simple process to prepare oxazoline compounds in excellent yields and selectivities. By using a fluoroalkanesulfonyl fluoride compound as a reagent, the present invention has the advantages of providing a process to efficiently convert acylamino alcohol compounds into oxazoline compounds with a remarkable variety of substrates, high chemoselectivity, mild conditions and relatively short reaction time. The present invention has the further advantage of providing a process for preparing oxazoline compounds whose stereoisomeric configuration can be easily determined aforehand simply by the selection of the appropriate starting materials.
Other objects, features, advantages and aspects of the present invention will become apparent to those skilled in the art from the following description and appended claims. It should be understood, however, that the following description, appended claims, and specific examples, while indicating preferred embodiments of the invention, are given by way of illustration only. Various changes and modifications within the spirit and scope of the disclosed invention will become readily apparent to those skilled in the art from reading the following.
Detailed Description of the Invention Listed below are definitions of various terms used to describe the compounds of the present invention. These definitions apply to the terms as they are used throughout the specification unless they are otherwise limited in specific instances either individually or part of a larger group.
The term "optionally substituted alkyl" refers to unsubstituted or substituted straight or branched-chain hydrocarbon groups having 1 -20 carbon atoms, preferably 1 -7 carbon atoms. Exemplary unsubstituted alkyl groups include methyl, ethyl, propyl, isopropyl, n-butyl, f-butyl, isobutyl, pentyl, neopenthyl, hexyl, isohexyl, heptyl, octyl and the like. Substituted alkyl groups include, but are not limited to, alkyl groups substituted by one or more of the following groups: halo, cyano, hydroxyl, acyl, alkoxy, carboxyl, amino, alkylamino, dialkylamino, cycloalkyl, alkenyl, or heterocyclyl.
The term "lower alkyl" refers to those optionally substituted alkyl groups as described above having 1-7 carbon atoms.
The term "alkoxy" refers to optionally substituted alkyl-O-. The term "alkenyl" refers to any of the above alkyl groups having at least two carbon atoms and further containing a carbon to carbon double bond at the point of attachment.
The term "alkynyl" refers to any of the above alkyl groups having at least two carbon atoms and further containing a carbon to carbon triple bond at the point of attachment.
The term "halogen" or "halo" refers to fluorine, chlorine, bromine and iodine. The term "cycloalkyl" refers to optionally substituted monocyclic aliphatic hydrocarbon groups of 3-6 carbon atoms, which may be substituted by one or more substitutents, such as optionally substituted alkyl, aryl, halo, cyano, hydroxyl, carboxyl, and amino. Exemplary monocyclic hydrocarbon groups include, but are not limited to, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl and the like.
The terms "alkylamino" and "dialkylamino" refer to alkyl-NH- and (alkyl)2N-, respectively.
The term "aryl" refers to a carbocyclic moiety containing at least one benzenoid-type ring, with the aryl groups preferably containing from 6 to 15 carbon atoms, for example, phenyl, naphthyl, indenyl or indanyl, which may optionally be substituted by 1 -4 substitutents, such as optionally substituted alkyl, aryl, cyano, carboxyl, amino, halo or alkoxy.
The term "polycyclic arylyl" refers to an optionally substituted, fully saturated or unsaturated, aromatic or non-aromatic cyclic group, for example, which is a 4- to 7-membered monocyclic, 7- to 12- membered bicyclic, or 10- to 15-membered tricyclic ring system. Substituted polycyclic aryl groups refer to polycyclic groups substituted with 1 , 2 or 3 substituents selected from the group consisting of: optionally substituted alkyl, halo, cyano, hydroxyl, carboxyl, and amino. The term "aralkyl" refers to an aryl group bonded directly through an alkyl group, such as benzyl or phenethyl.
The term "heterocyclyl" or "heterocyclo" refers to an optionally substituted, fully saturated or unsaturated, aromatic or non-aromatic cyclic group, for example, which is a 4- to 7-membered monocyclic, 7- to 12- membered bicyclic, or 10- to 15- membered tricyclic ring system, which has at least one heteroatom in at least one carbon atom containing ring. Each ring of the heterocyclic group containing a heteroatom may have 1 , 2 or 3 heteroatoms selected from nitrogen atoms, oxygen atoms and sulfur atoms, where the nitrogen and sulfur heteroatoms may also optionally be oxidized. The heterocyclic group may be attached at a heteroatom or a carbon atom.
The terms "heterocyclyl" includes substituted heterocyclic groups. Substituted heterocyclic groups refer to heterocyclic groups substituted with 1 , 2 or 3 substituents selected from the group consisting of: optionally substituted alkyl, halo, cyano, hydroxyl, and amino. The term "fluorinated alkyl" refers to a fluorinated alkyl group having from 1 to about 10 carbon atoms; substituted or fluorinated ether groups (e.g., HC2F4OC2F4-, IC2F4OC2F4-, CIC2F4OC2F4-); or substituted or fluorinated esther groups (e.g., MeOOCCF2-).
The term "fluorinated aryl" refers to a fluorinated cycloalkyl group having from about 4 to 8 carbon atoms.
As described herein above, the present invention relates to a method for preparing oxazoline compounds of formula (I) with a suitable organic basic reagent and a fluoroalkanesulfonyl fluoride compound of formula (II). The process of the present invention is particularly useful to prepare high yields of a chemospecific oxazoline compound. The process of the present invention is particularly useful to prepare an oxazoline compound with a remarkable variety of substrates, mild conditions and relatively short reaction time.
The acylamino alcohols suitable for use with the process of the invention include compounds of the formula:
Figure imgf000008_0001
wherein
Ri and R2 are independently hydrogen, sulfide, sulfoxide, sulfonyl, optionally substituted lower alkyl or alkenyl or alkynyl, optionally substituted aralkyl, optionally substituted aryl or optionally substituted polycyclic arylyl; or
Ri and R2 combined together with the carbon atoms to which they are attached form an optionally substituted fused 6-member aromatic ring provided that Ri and R2 are attached to carbon atoms adjacent to each other; and
R3 is hydrogen, sulfide, sulfoxide, sulfonyl, optionally substituted lower alkyl, optionally substituted aralkyl, optionally substituted aryl or optionally substituted polycyclic arylyl.
The acylamino alcohols useful in the present invention include N-acylamino alcohols, wherein R2 in the compound of formula (III) is hydrogen, or an N-acyl-1 ,2- disubstituted amino alcohol The acylamino alcohols useful in the present invention are known compounds that are industrially produced and available commercially. Representative methods of preparing N-acylamino alcohols are described in European Patent Application 0075868. However, other methods of preparing N-acylamino alcohols that are well- known to one skilled in the art may be used. The preparative teachings of these references are incorporated herein by reference.
Sulfonyl fluoride compounds suitable for use in the process of the invention are fluorinated saturated aliphatic or alicyclic sulfonyl fluorides. A useful class of such fluoroalkanesulfonyl fluoride compounds can be represented by the general formula R1SO2F, where Ri is selected from the group consisting of fluorinated alkyl groups having from 1 to about 10 carbon atoms and fluorinated cycloalkyl groups having from about 4 to about 8 carbon atoms. Preferably, Ri is a perfluorinated alkyl group. Representative samples of fluoroalkanesulfonyl fluoride compounds suitable for the use in the process of this invention include CF3SO2F, C2F5SO2F, C4F92F, C6Fi3SO2F, C8Fi7SO2F, Ci0F2iSO2F, cyclo-(C6Fn)SO2F, C2F5-cyclo-(C6Fi0)SO2F, H(CF2)4SO2F, H(CF2)8SO2F, and mixtures thereof. Preferably, perfluorobutanesulfonyl fluoride, perfluorohexanesulfonyl fluoride, perfluoroctane sulfonyl fluoride, and mixtures thereof are utilized. Most preferably, perfluorobutanesulfonyl fluoride is utilized in the process of the present invention. The fluoroalkanesulfonyl fluoride compounds of the present invention are industrially produced and available commercially as fine chemicals. Representative methods of preparing the fluoroalkanesulfonyl fluoride compounds of formula (II) are described in U.S. Patent Nos. 2,732,398; 5,318,674 and 5,486,281. Other representative methods of preparing the fluoroalkanesulfonyl fluoride compounds used in the present invention are described in M. Novikova et al., J. Fluorine Chem. 58, 326 (1992) and N. D. Volkov et al., Syntheses, 972 (1979). The preparative teachings of these references are incorporated herein by reference. The fluoroalkanesulfonyl fluoride fluoride compound may be used in molar ratios (moles sulfonyl fluoride compound to moles amino alcohol) ranging from about 100 to 0.1 :1 , more preferably from about 10 to 0.1 :1 , most preferably about 1.5 : 1.
This claimed method for converting acylamino alcohols to oxazoline compounds by fluoroalkanesulfonyl fluoride compounds may be performed with untreated organic basic reagents commonly containing 0.1 - 4 percent of water, more preferably about 0.05 - 0.5 percent of water. Organic basic reagents suitable for use in the process of the invention include a non-aqueous base such as lithium diisopropyl amide, lithium hexamethylsilazide, sodium hexamethylsilazide and potassium hexamethylsilazide; or potassium t-butoxide and sodium methoxide. The base can be an alkali metal carbonate such as sodium, potassium, lithium or cesium carbonate or an alkaline earth metal carbonate such as calcium or barium carbonate; hydroxides such as sodium and potassium hydroxides; and hydrides such as sodium or potassium hydrides. The base can also be ammonia (NH3) or an organic base including urea; a secondary amine such as dimethylamine, diphenylamine, N-methyl N-propylamine, diethylamine, diisopropylamine, N-methylaniline, piperazine, piperidine, pyrrolidine; or a tertiary amine such as diisopropylethylamine (DIPEA), trimethylamine, dimethylaniline, N,N-dimethylpropylamine, N,N-dimethylpiperidine, N,N-dimethylbutylamine, triethylamine (TEA). The base can also be an heterocyclic nitrogen containing compound such as isoquinoline, morpholine, purine, pyridine, pyrazine, pyrimidine, quinoline or polyvinyl pyridine, preferably DMAP or DBU. Where appropriate, mixtures of any of the above bases can be employed.
The organic basic reagent may be used in molar ratios (moles base to moles amino alcohol) ranging from about 1 ,000 to 0.001 : 1 , more preferably from about 10 to 0.01 : 1 , most preferably about 3: 1. If desired, the claimed method of the present invention may be performed by additionally including an inert organic solvent such as toluene, hexane, pentane, benzene, acetonitrile, acetone, tetrahydrofuran (THF), ethyl acetate, dichloromethane (CH2Cb or DCM), triethylamine, CDCI3 Or a mixture of solvents thereof. Preferably, the method of the present invention includes dichloromethane or CDCI3. In the process of preparing the oxazoline compound of formula (I), the N- acylamino alcohol of formula (III) is contacted with a fluoroalkanesulfonyl fluoride compound of formula (II) and an organic basic reagent in amounts and under conditions effective to yield the desired oxazoline compound. The contacting may optionally be performed in an inert organic solvent. The fluoroalkanesulfonyl fluoride compound (II) and organic basic reagent are contacted with the N-acylamino alcohol at temperatures ranging from 19-25°C, preferably from about 21 -23°C, most preferably at 22°C. The contact is performed at ambient pressures although pressures greater or less than ambient can be employed. The contacting of the reactants can be carried out for about 3 minutes to about 48 hours until the reaction is substantially completed, preferably from about 5 minutes about 24 hours. The mixture is preferably stirred while the reactants are being contacted.
Upon completion of the reaction, oxazoline can be removed from remaining water by extraction from methylene chloride or other methods well known to one skilled in the art. The oxazoline is preferably formed in yield of at least about 55 percent based upon the initial amount of the N-acylamino alcohol, more preferably in yields of at least 85 percent, and most preferably in yields of at least about 87 percent.
The effectiveness of the method of the present invention is illustrated in Table 1 for the synthesis of 2,4-substituted oxazoline compounds having the formula (IV):
Figure imgf000011_0001
wherein Ri is sulfide, sulfoxide, sulfonyl, optionally substituted lower alkyl, optionally substituted aralkyl, optionally substituted aryl or optionally substituted polycyclic arylyl; and
R2 is sulfide, sulfoxide, sulfonyl, optionally substituted lower alkyl, optionally substituted aralkyl, optionally substituted aryl or optionally substituted polycyclic arylyl.
Table 1 illustrates that the method of the present invention may be used with a wide range of acylamino alcohol substrates to form their corresponding oxazoline compound. All the substituted derivatives 1 a - 1 q (entries 1-17), including those amides containing heterocyclic substituents 11 and 1 m, were readily converted to their corresponding oxazolines in nearly quantitative yields.
The present invention is an effective method for the preparation of an oxazoline compound with high chemoselectivity. Cyclization of N-acylamino alcohols bearing an unprotected second hydroxyl group can be achieved with careful addition of perfluorobutanesulfonyl fluoride with DBU as a base. As illustrated in Table 1 , N- acylamino alcohol 1 q bearing an unprotected secondary hydroxyl group was cyclized to form oxazoline compound 2q (93% isolated yield) with careful addition of 1.1 -1.2 equiv of PFBSF with DBU as base in 5 ml_ of dichloromethane as solvent.
In one particular embodiment, the present invention provides a method for the preparation of serine-derived oxazolines, which are interesting moieties of some natural products. N-acylamino alcohols may be reacted with a fluorinated, sulfonyl fluoride and organic basic reagent to form oxazolines derived from serine. As illustrated in Table 1 , this embodiment of the present invention preferably uses perfluorobutanesulfonyl fluoride as the fluoroalkanesulfonyl fluoride compound. This embodiment of the present invention also uses DIPEA or DMAP as an organic basic reagent. Oxazoline compounds 2r - 2w were synthesized using perfluorobutanesulfonyl fluoride and DMAP at approximately 90 percent yield. Further, oxazoline compounds 2x and 2y were synthesized using perfluorobutanesulfonyl fluoride and DIPEA at 85-87 percent yield .
Table 1. Synthesis of 2,4-substituted oxazolinesa
Figure imgf000013_0001
product entry substrates (R1, R2) base time yieldb
S
1 Ia (R)-Ph-, Ph- DBU 5min 2a 99
2 1b (S)-t-Bu-, Ph- DBU 5min 2b 99
3 Ic (S)-Et-, Ph- DBU 5min 2c 97
4 1d dimethyl-, Ph- DBU 5min 2d 96
5 Ie (R)-Ph-, 2-tolyl DBU 5min 2e 98
6 1f (R)-Ph-, 3-tolyl DBU 5min 2f 95
7 1g (R)-Ph-, 4-tolyl DBU 5min 2g 95
8 Ih (R)-Ph-, t-Bu- DBU 5min 2h 96
9 Ii (R)-Ph-, 4-MeOPh- DBU 5min 2i 99
10 1j (R)-Ph-, 4-NO2Ph- DBU 5min 2j 91
11 Ik (R)-Ph-, 2,6-(MeO)2Ph- DBU 5min 2k 99
12 11 (R)-Ph-, 2-furyl- DBU 5min 2I 98
13 1m (R)-Ph-, 2-pyridinyl- DBU 5min 2m 98
14 In (R)-Ph-, Me2N- DBU 5min 2n 94
15 1o (R)-Ph-, CF3- DBU 5min 2o 92
16 Ip (R)-Ph-, Me- DBU 5min 2p 92
17 1q (S,S)-PhCH(OH)-, Ph- DBU 5min 2q 93C
18 Ir (S)-CO2Me, PhDMAP 3h 2r 92
19 is (S)-CO2Me, o-tolyl DMAP 3h 2s 87
20 1t (S)-CO2Me, m-tolyl DMAP 3h 2t 88
21 1u (S)-CO2Me, p-tolyl- DMAP 3h 2u 93
22 1v (S)-CO2Me, p-MeOPh- DMAP 3h 2v 92
23 Iw(S)-CO2Me, t-Bu- DMAP 3h 2w 92
24 1x (S)-CO2Me, 2-furyl- DIPEA 24h 2x 85
25 1y (S)-CO2Me, 4-NO2Ph- DIPEA 24h 2y 87 a. 0.5 mmol of amides, 3 equiv of base and 1.5 equiv of PFSBF in 5 ml_ of CH2CI2 at rt. b. Isolated yield(%). c. 1.1 -1.2 equiv of PFSBF was used with 1H NMR trace. In an alternative embodiment, the method of the present invention may be used to prepare 2,4,5-trisubstituted oxazoline compounds of formula (I), wherein Ri and R2 are independently hydrogen, sulfide, sulfoxide, sulfonyl, optionally substituted lower alkyl, optionally substituted aralkyl, optionally substituted aryl or optionally substituted polycyclic arylyl; or Ri and R2 combined together with the carbon atoms to which they are attached form an optionally substituted fused 6-member aromatic ring provided that Ri and R2 are attached to carbon atoms adjacent to each other; and R3 is sulfide, sulfoxide, sulfonyl, optionally substituted lower alkyl, optionally substituted aralkyl, optionally substituted aryl or optionally substituted polycyclic arylyl. In the process of preparing the 2,4,5-trisubstituted oxazoline compound, an N-acyl-1 ,2-disubstituted amino alcohol is contacted with a fluoroalkanesulfonyl fluoride compound of formula (II) and an organic basic reagent in amounts and under conditions effective to yield the desired oxazoline compound. The fluoroalkanesulfonyl fluoride compound (II) and organic basic reagent are contacted with the N-acylamino alcohol at temperatures ranging from 19-25°C, preferably from about 21-23°C, most preferably at 22°C. The contact is performed at ambient pressures although pressures greater or less than ambient can be employed. The contacting of the reactants can be carried out for about 3 minutes to about 48 hours until the reaction is substantially completed, preferably from about 5 minutes about 24 hours. The mixture is preferably stirred while the reactants are being contacted.
Table 2 illustrates that the method of the present invention may be used to prepare 2,4,5-trisubstituted oxazoline compound with regiochemical specificity. It is known that the analogous reaction using conventional activating reagents (e.g. TsCI) often requires more forceful conditions because of increased steric hindrance for the cyclization with secondary alcohols. Moreover, it is further known that 1 ,2- disubstituted amino alcohols are rather prone to epimerization via the SN1 pathway. In one embodiment, the method of the present invention may be used to convert 1 , 2-disubstituted amino alcohols to an oxazoline compound with an inverted configuration. As set forth in Table 2, the acylamino alcohol 3a may be contacted with perfluorobutanesulfonyl fluoride and DBU to synthesize the oxazoline compound 4a at 98% yield.
The method of the present invention may be used to produce numerous 2, 4, 5- trisubstituted oxazoline compounds at high yield. By reacting a 1 , 2-disubstituted amino alcohol with a suitable amount of fluoroalkanesulfonyl fluoride compound and organic basic reagent, the method of the present invention may be efficiently employed with a variety of substrates, including for example, substrates derived from erythro-am\no alcohols, Λ/-acylamino indanol, and other common 1 , 2-disubstituted amino alcohols that are known to one skilled in the art.
In another embodiment, the method of the present invention may be used to synthesize higher yields of 4, 5-oxazoline from ffrreo-amides than available with conventional techniques using, for example, reagents such as BF3- Et2O or TsCI. Formation of 4, 5-oxazoline from threo-am\de is known to be problematic due to unfavored non-bonding interaction resulting in the formation of the thermally stable 4,5-frans-isomer rather than c/s-oxazoline. For example, as illustrated in Table 2, the method of the present invention may be used to effect cyclization of threo-am\de compound 3h with a suitable amount of perfluorobutanesulfonyl fluoride and DBU as base to form c/s-4h in 55% isolated yield along with < 10% frans-isomer (entry 8).
Table 2. Synthesis of 2,(4,)5-substituted oxazolinesa
Figure imgf000016_0001
3a-h 4a -h entry substrates products time yielcf
Figure imgf000016_0002
a. All reactions were performed on 0.5 mmol of amide with 3equiv of DBU and 1.5 equiv of PFBSF. b. Isolated yield, d. Reaction with 5mmol substrates, e. DMAP as base.
Oxazolines synthesized by the present process are useful monomers for making known functional polymers that are used as effective auxiliaries and ligands for selected asymmetric syntheses, monomers in ring opening polymerizations, and valuable intermediates in organic synthesis. The present invention providing a process to efficiently prepare a high yield of highly chemoselective oxazoline compounds from acylamino alcohol compounds under mild conditions and relatively short reaction time. The simple protocol for the present invention provides an excellent opportunity for large-scale applications. The following Examples are intended to further illustrate the invention and are not to be construed as being limitations otherwise. The structure of products and starting materials is confirmed by standard analytical methods, e.g., microanalysis, melting point, high pressure liquid chromatography (HPLC) and spectroscopic characteristics, e.g., MS, IR, NMR. Abbreviations are those conventional in the art.
Example 1 - Synthesis of 2-ethoxy-4-phenyl-4,5-dihydrooxazole
Figure imgf000017_0001
Λ/-ethoxycarbonyl amino alcohol (0.5 mmol), perfluorobutanesulfonyl fluoride
(0.75 mmol), and DIPEA (1.5 mmol) are charged into a 25 ml_ flask with a magnetic stirring bar. 5 ml_ of CH2Cb is added to the 25 ml_ flask. The mixture is stirred for 24 hours at 22°C. The residue is purified by flash column chromatography on silica gel (1 :10 ethyl acetate: hexane) giving (R)- 2-ethoxy-4-phenyl-4,5-dihydrooxazole in 91 percent yield.
[α]20D = -17.5 (c = 2.0, CHCI3), 1H NMR (500 MHz, CDCI3) δ 7.42 - 7.18 (m, 5H), 5.13 (dd, J = 7.9, 9.3, 1 H), 4.71 (dd, J = 8.3, 9.4, 1 H), 4.45 - 4.28 (m, 2H), 4.17 (t, J = 7.9, 1 H), 1.39 (t, J = 7.1 , 3H); 13C NMR (126 MHz, CDCI3) δ 163.6, 142.7, 128.6, 127.5, 126.3, 75.5, 67.0, 66.7, 14.3. [NMR: Fraile, J. M.; Garcia, J. I.; Herrerias, C. I.; Mayoral, J. A.; Reiser, 0.; Socuellamos, A.; Werner, H. Chem.-Eur. J. 2004, 10, 2997-3005.]
Example 2 - Synthesis of 2,4-diphenyl-4,5-dihydrooxazole
Figure imgf000018_0001
N-acylamino alcohol (0.5 mmol), DBU (3.0 mmol) and 5 ml_ of CH2CI2 at 00C are charged into a 25 ml_ flask with a magnetic stirring bar. Perfluorobutanesulfonylfluoride (1.5 mmol) is added to the 25 ml_ flask. The mixture is stirred for 5 minutes at room temperature and then concentrated under reduced pressure. The residue is purified by flash column chromatography on silica gel (1 :10 ethyl acetate: hexane) giving 2,4-diphenyl-4,5-dihydrooxazole in 99 percent yield. [O]20 D = + 48.3 (c = 1.0, CHCI3), 1H NMR (500 MHz, CDCI3) δ 8.10 - 8.04 (m , 2H), 7.56 - 7.26 (m, 8H), 5.40 (dd, J = 8.2, 10.1 , 1 H), 4.81 (dd, J = 8.4, 10.1 , 1 H), 4.29 (t, J = 8.3, 1 H); 13C NMR (126 MHz, CDCI3) δ 164.7, 142.3, 131.5, 128.7, 128.5, 128.4, 127.6, 127.5, 126.7, 74.9, 70.0. [NMR : Gorunova, O. N.; Keuseman, K. J.; Goebel, B. M.; Kataeva, N. A.; Churakov, A. V.; Kuz'mina, L. G.; Dunina, V. V.; Smoliakova, I. P. J. Organomet. Chem. 2004, 689, 2382-2394. ] Example 4 - Synthesis of (S)-methyl 2-(furan-2-yl)-4,5-dihydrooxazole-4-carboxylate
Figure imgf000019_0001
N-acylamino alcohol (compound I q)(0.5 mmol), perfluorobutanesulfonyl fluoride (0.75 mmol), and DIPEA (1.5 mmol) are charged into a 25 ml_ flask with a magnetic stirring bar. 5 ml_ of CH2Cb is added to the 25 ml_ flask. The mixture is stirred for 24 hours at room temperature. The residue is purified by flash column chromatography on silica gel (1 :10 ethyl acetate: hexane) giving (S)-methyl 2-(furan- 2-yl)-4,5-dihydrooxazole-4-carboxylate as a white waxy solid in 85 percent yield: [α]20D = + 85.3 (c = 2.0, CHCI3), 1H NMR (500 MHz, CDCI3) δ7.52 (dd, J = 0.6, 1.6, 1 H), 7.00 (d, J = 3.5, 1 H), 6.46 (dd, J = 1.8, 3.5, 1 H), 4.91 (dd, J = 7.9, 10.4, 1 H), 4.64 (dd, J = 8.1 , 8.5, 1 H), 4.54 (dd, J = 8.7, 10.4, 1 H), 3.77 (s, 3H); 13C NMR (126 MHz, CDCI3) δ 171.2, 158.3, 145.6, 142.1 , 115.5, 111.6, 69.6, 68.3, 52.7. [NMR: Pirrung, M. C; Tumey, L. N. J. Comb. Chem., 2, 675-680 (2000).]
Example 5 - Synthesis of (S)-methyl 2-(4-nitrophenyl)-4,5-dihydrooxazole-4- carboxylate
Figure imgf000019_0002
N-acylamino alcohol (compound 1 r)(0.5 mmol), perfluorobutanesulfonyl fluoride (0.75 mmol), and DIPEA (1.5 mmol) are charged into a 25 ml_ flask with a magnetic stirring bar. 5 ml_ of CH2CI2 is added to the 25ml_ flask. The mixture is stirred for 24 hours at room temperature. The residue is purified by flash column chromatography on silica gel (1 :10 ethyl acetate: hexane) giving (S)-methyl 2-(4- nitrophenyl)-4,5-dihydrooxazole-4-carboxylate as a white waxy solid in 87 percent yield: mp = 86-87°C [α]20 D = + 33.9 (c = 1.0, CHCI3), 1H NMR (500 MHz, CDCI3) δ 8.28 - 8.20 (m, 2H), 8.17 - 8.09 (m, 2H), 4.99 (dd, J = 8.2, 10.6, 1 H), 4.74 (t, J = 8.5, 1 H), 4.65 (dd, J = 8.8, 10.6, 1 H), 3.81 (s, 3H); 13C NMR (126 MHz, CDCI3) δ 171.0, 164.3, 149.7, 132.6, 129.6, 123.5, 70.0, 68.7, 52.8. [NMR: Pirrung, M. C; Tumey, L. N. J. Comb. Chem., 2, 675-680 (2000).]
Example 6 - Synthesis of 2-phenyl-3a,4,5,6,7,7a-hexahydrobenzo[d]oxazole
Figure imgf000020_0001
N-acylamino alcohol (compound 1x)(0.5 mmol), perfluorobutanesulfonyl fluoride (0.75 mmol), and DIPEA (1.5 mmol) are charged into a 25 ml_ flask with a magnetic stirring bar. 5 ml_ of CH2Cb is added to the 25ml_ flask. The mixture is stirred for 24 hours at room temperature. The residue is purified by flash column chromatography on silica gel (1 :10 ethyl acetate: hexane) giving 2-phenyl- 3a,4,5,6,7,7a-hexahydrobenzo[d]oxazole as a white waxy solid in 98 percent yield: 1H NMR (500 MHz, CDCI3) δ 8.00 - 7.91 (m, 2H), 7.54 - 7.33 (m, 3H), 4.68 (dt, J = 5.3, 8.1 , 1 H), 4.13 (dt, J = 6.3, 8.0, 1 H), 1.99 - 1.27 (m, 8H).; 13C NMR (126 MHz, CDCI3) δ 164.2, 131.1 , 128.3, 128.2, 128.1 , 78.8, 63.5, 27.7, 26.2, 19.8, 19.1.[NMR: Crosignani, S.; Swinnen, D. J. Comb. Chem., 7, 688-96 (2005).]
Example 7 - Synthesis of 4-methyl-2,5-diphenyl-4,5-dihydrooxazole Jl ϊ nu DBU1PFBSF
Figure imgf000021_0001
Amide 3b (5.0 mmol), perfluorobutanesulfonyl fluoride (7.50 mmol), and DBU (15.0 mmol) are charged into a 50 ml_ flask with a magnetic stirring bar. 10 ml_ of CH2Cb is added to the 5OmL flask. The mixture is stirred for 30 minutes at room temperature. The residue is purified by flash column chromatography on silica gel (1 :10 ethyl acetate: hexane) giving 4-methyl-2,5-diphenyl-4,5-dihydrooxazole in 99 percent yield.
[Q]20D = - 46.7, (c = 2.0, CHCI3), 1H NMR (500 MHz, CDCI3) δ 8.03 (d, J = 7.3, 2H), 7.59 - 7.28 (m, 8H), 5.11 (d, J = 7.8, 1 H), 4.25 - 4.17 (m, 1 H), 1.50 (d, J = 6.7, 3H); 13C NMR (126 MHz, CDCI3) δ 162.7, 140.5, 131.4, 128.8, 128.4, 128.3, 128.3, 127.7, 125.6, 88.2, 71.0, 21.4. [NMR, Lafargue, P.; Guenot, P.; Lellouche, J. P. Heterocycles 1995, 41, 947-958.]
Example 8 - Synthesis of optically pure antibiotic
DMAP{3eq),
Figure imgf000021_0004
Figure imgf000021_0003
Figure imgf000021_0002
Bis-hydroxyl amide (0.5 mmol), perfluorobutanesulfonyl fluoride (0.6 mmol), and DMAP (1.5 mmol) are charged into a 25 ml_ flask with a magnetic stirring bar. 5 ml_ of CH2CI2 is added to the 25ml_ flask. The mixture is stirred for 3 hours at 22°C. Purification by chromatography column provided analytical pure title compound in 87 percent yield. [α]20D = + 87.1 (c = 2.0, CHCI3), + 81.5 (c = 2.0, MeOH), 1H NMR (500 MHz, CDCI3) δ 11.67 (s, 1 H), 7.64 (dd, J = 1.4, 7.9, 1 H), 7.42 - 7.34 (m, 1 H), 7.00 (d, J = 8.4, 1 H), 6.86 (t, J = 7.6, 1 H), 4.96 (dd, J = 7.5, 10.4, 1 H), 4.66 (t, J = 8.1 , 1 H), 4.55 (dd, J = 8.9, 10.4, 1 H), 3.79 (s, 4H); 13C NMR (126 MHz, CDCI3) δ 170.9, 167.4, 159.8, 133.9, 128.3, 118.7, 116.8, 109.9, 68.8, 67.1 , 52.7.[NMR: Sasaki, T.; Otani, T.; Yoshida, K.; Unemi, N.; Hamada, M.; Takeuchi, T. J. Antibiot. 1997, 50, 881 -883.]

Claims

What is claimed is: 1. A process preparing an oxazoline compound of the formula
Figure imgf000023_0001
wherein Ri and R2 are independently hydrogen, sulfide, sulfoxide, sulfonyl, optionally substituted lower alkyl, optionally substituted aralkyl, optionally substituted aryl or optionally substituted polycyclic arylyl; or
Ri and R2 combined together with the carbon atoms to which they are attached to form an optionally substituted fused 6-member aromatic ring provided that Ri and R2 are attached to carbon atoms adjacent to each other; and
R3 is hydrogen, sulfide, sulfoxide, sulfonyl, optionally substituted lower alkyl, optionally substituted aralkyl, optionally substituted aryl or optionally substituted polycyclic arylyl; or an enantiomer therof; or an enantiomeric mixture thereof; comprising contacting a fluoroalkanesulfonyl fluoride compound and an organic basic reagent with an N-acylamino alcohol compound of the formula
Figure imgf000023_0002
wherein, Ri, R2 and R3 are as defined above, or a salt thereof.
2. A process according to claim 1 , wherein Ri and R2 combined together with the carbon atoms to which they are attached to form an optionally substituted fused 6-member aromatic ring provided that Ri and R2 are attached to carbon atoms adjacent to each other.
3. A process according to claim 1 , wherein the fluoroalkanesulfonyl fluoride compound is a perfluoroalkanesulfonyl fluoride.
4. A process according to claim 4, wherein the perfluoroalkanesulfonyl fluoride is perfluorobutanesulfonyl fluoride.
5. A process according to claim 1 , wherein the organic basic reagent is DBU.
6. A process according to claim 1 , wherein the organic basic reagent is DMAP.
7. A process according to claim 1 , wherein the organic basic reagent is DIPEA.
8. A process according to claim 1 , wherein a compound of formula (I) has the formula
Figure imgf000024_0001
wherein
Ri is an optionally substituted lower alkyl, optionally substituted aralkyl, optionally substituted aryl or optionally substituted polycyclic arylyl; R2 is a hydrogen; and
R3 is an optionally substituted lower alkyl, optionally substituted aralkyl, optionally substituted aryl or optionally substituted polycyclic arylyl; or an entiomer therof; or an entiomeric mixture thereof.
9. A process according to claim 8, wherein the fluoroalkanesulfonyl fluoride compound is a perfluoroalkanesulfonyl fluoride.
10. A process according to claim 9, wherein the perfluoroalkanesulfonyl fluoride is perfluorobutanesulfonyl fluoride.
11. A process according to claim 8, wherein the organic basic reagent is DBU.
12. A process according to claim 8, wherein the organic basic reagent is DMAP.
13. A process according to claim 1 , wherein the organic basic reagent is DIPEA.
14. A process according to claim 1 , wherein a compound of formula (I) has the formula
Figure imgf000025_0001
wherein Ri and R2 are independently hydrogen, sulfide, sulfoxide, sulfonyl, optionally substituted lower alkyl, optionally substituted aralkyl, optionally substituted aryl or optionally substituted polycyclic arylyl; or
Ri and R2 combined together with the carbon atoms to which they are attached to form an optionally substituted fused 6-member aromatic ring provided that Ri and R2 are attached to carbon atoms adjacent to each other; and
R3 is an optionally substituted aryl; or an entiomer therof; or an entiomeric mixture thereof.
15. A process according to claim 6, wherein R3 is an optionally substituted phenyl.
16. A process according to claim 14, wherein the fluoroalkanesulfonyl fluoride compound is a perfluoroalkanesulfonyl fluoride.
17. A process according to claim 16, wherein the perfluoroalkanesulfonyl fluoride is perfluorobutanesulfonyl fluoride.
18. A process according to claim 14, wherein the organic basic reagent is DBU.
19. A process according to claim 14, wherein the organic basic reagent is DMAP.
20. A process according to claim 14, wherein the organic basic reagent is DIPEA.
PCT/CN2009/073136 2008-08-07 2009-08-07 Synthesis of oxazoline compounds WO2010015211A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8687808P 2008-08-07 2008-08-07
US61/086,878 2008-08-07

Publications (1)

Publication Number Publication Date
WO2010015211A1 true WO2010015211A1 (en) 2010-02-11

Family

ID=41663295

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2009/073136 WO2010015211A1 (en) 2008-08-07 2009-08-07 Synthesis of oxazoline compounds

Country Status (1)

Country Link
WO (1) WO2010015211A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102180841A (en) * 2011-04-08 2011-09-14 上海大学 2-bromodifluoromethyl substituted 1,3-oxazoline compound and synthesis method thereof
CN102336750A (en) * 2011-09-16 2012-02-01 西北师范大学 Method for preparing Chiral pyridinebis(oxazoline) ligand
CN102702123A (en) * 2012-06-12 2012-10-03 上海大学 Chiral 2-fluoroalkyl-4-phenyl-1,3-oxazoline compound and synthesizing method thereof
CN105693647A (en) * 2016-01-11 2016-06-22 浙江大学 Chiral compounds containing imine oxazoline amine and preparing method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5318674A (en) * 1993-06-30 1994-06-07 Minnesota Mining And Manufacturing Company Process for preparing perfluoroalkanesulfonyl fluorides
US20050075506A1 (en) * 2003-10-06 2005-04-07 Handa Vijay Kumar Process for preparing florfenicol

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5318674A (en) * 1993-06-30 1994-06-07 Minnesota Mining And Manufacturing Company Process for preparing perfluoroalkanesulfonyl fluorides
US20050075506A1 (en) * 2003-10-06 2005-04-07 Handa Vijay Kumar Process for preparing florfenicol

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102180841A (en) * 2011-04-08 2011-09-14 上海大学 2-bromodifluoromethyl substituted 1,3-oxazoline compound and synthesis method thereof
CN102336750A (en) * 2011-09-16 2012-02-01 西北师范大学 Method for preparing Chiral pyridinebis(oxazoline) ligand
CN102702123A (en) * 2012-06-12 2012-10-03 上海大学 Chiral 2-fluoroalkyl-4-phenyl-1,3-oxazoline compound and synthesizing method thereof
CN102702123B (en) * 2012-06-12 2014-10-01 上海大学 Chiral 2-fluoroalkyl-4-phenyl-1,3-oxazoline compound and synthesizing method thereof
CN105693647A (en) * 2016-01-11 2016-06-22 浙江大学 Chiral compounds containing imine oxazoline amine and preparing method thereof

Similar Documents

Publication Publication Date Title
CA2699438C (en) Method for preparing disubstituted piperidine and intermediates
US10035772B2 (en) Processes for the preparation of 4-alkoxy-3-(acyl or alkyl)oxypicolinamides
CA2961984C (en) Novel chiral synthesis of n-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines
EP2240441B1 (en) Process for the preparation of 6-substituted-1-(2h)-isoquinolinones
WO2010015211A1 (en) Synthesis of oxazoline compounds
RU2713400C9 (en) Method of producing 5r-[(benzyloxy)amino]piperidine-2s-carboxylate and oxalates thereof
US11760723B2 (en) Method of preparing a DON prodrug from L-pyroglutamic acid
JP5304818B2 (en) Process for producing 4-substituted or unsubstituted tetrahydropyran-4-carboxylic acid compound or ester compound thereof
EP2479166A1 (en) A process for the preparation of etoricoxib
US4803270A (en) Process of producing fluoroaniline derivatives
EP0237899B1 (en) Production of fluoroaniline derivatives
KR20120093237A (en) Process for preparing biphenyl imidazole compounds
US6320057B1 (en) Intermediates for the preparation of 2-imidazoline-5-ones
EP2982673B1 (en) Process for manufacturing 5-chloromethyl-2,3-dicarboxylic anhydride
FI94635B (en) Process for the preparation of oxazoline derivatives
JP2019536746A (en) Method for producing phenylalanine compound
CN109053631B (en) Synthetic method for synthesizing benzo [1,3] oxazine-2-thioketone through isothiocyanate and 2-sulfonyl alkyl phenol
KR19990008411A (en) Improvement method of 4-hydroxy-2-pyrrolidone
KR0136706B1 (en) Process for 3-amino pyrrolidine derivatives
JPWO2012157504A1 (en) β-lactam compound and process for producing the same
US6388083B2 (en) Process for the synthesis of (2S)-phenyl-3-piperidone
RU2804663C2 (en) Method of producing two 4-{[(2s)-2-{4-[5-chloro-2-(1h-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2h)-il} butanoyl]amino}-2-fluorobenzamide derivatives
KR920003897B1 (en) Process for producting glutaconic acid derivatives
US20030153753A1 (en) Process for the preparation of a piperazine derivative
AU622332B2 (en) New azetidines, their preparation and their application as intermediates for the preparation of compounds with antimicrobial activity

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09804511

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09804511

Country of ref document: EP

Kind code of ref document: A1